Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Superior University
Improved detection rates of DCIS in high-risk patients. Enhanced diagnostic accuracy, reducing false positives and negatives. Ductal Carcinoma in situ (DCIS) is a non-invasive breast cancer where abnormal cells are confined to the milk ducts.
The Breast Imaging Reporting and Data System (BI-RADS) is a standardized scoring system used to classify breast imaging findings. Scores range from 0 (incomplete) to 6 (known biopsy-proven malignancy)."
Age
30–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
High-risk breast cancer patients with a family history of breast cancer or genetic predispositions (e.g., BRCA mutations).
Patients aged 30-65 years.
Patients willing to undergo breast MRI screening for DCIS detection.
You may not be if
Patients with contraindications to MRI imaging (e.g., pacemakers, claustrophobia).
Patients with a history of prior breast surgery or interventions that may interfere with imaging interpretation.
Clareo Health | Role of MRI Breast in Detection of Ductal Carcinoma in Situ
